Proud Sponsor of the Organization of Women in International Trade - Badge

Articles Posted in Merger Highlights

FTC Blocks Cooking Oil Merger Citing Some “Hot Docs”
Doyle, Barlow & Mazard PLLC

On March 5, 2018, the United States Federal Trade Commission (“FTC”) filed an administrative complaint alleging that J.M. Smucker Co.’s (“Smucker”) proposed $285 million acquisition of Conagra Brands, Inc.’s (“Conagra”) Wesson cooking oil brand may substantially lessen competition and reduce competition for canola and vegetable oils in the United States. Smucker currently owns the Crisco…

Continue reading ›
Close Coordination Between FTC and EC on Essilor and Luxottica Antitrust Reviews
Doyle, Barlow & Mazard PLLC

On March 1, 2018, Essilor International S.A. (“Essilor”) and Luxottica Group S.p.A. (“Luxottica”) announced that the proposed combination between the two companies has been cleared by both the FTC and the EC without conditions. Critics raised concerns about the merged company’s shutting out competitors, which would leave consumers with fewer options and less freedom of…

Continue reading ›
Is the Selective Enforcement Defense Applicable To Antitrust Cases?
Doyle, Barlow & Mazard PLLC

On February 21, 2018, Judge Leon ruled against AT&T Inc.’s (“AT&T”) ability to discover evidence that would support its selective enforcement defense. Background On November 21, 2017, the U.S. Department of Justice’s (“DOJ”) Antitrust Division filed a complaint in federal court block AT&T’s acquisition of Time Warner Inc. (“Time Warner”). On February 16, 2018, the…

Continue reading ›
FTC Says No More Divestitures of Complex Pipeline Products to Resolve Future Competition Concerns in Pharmaceutical Mergers
Doyle, Barlow & Mazard PLLC

On February 2, 2018, Bruce Hoffman, the Federal Trade Commission’s (“FTC”) acting Director of the Bureau of Competition, announced at the Global Competition Review Seventh Annual Antitrust Law Leaders Forum that the FTC will no longer accept divestitures of inhalant and injectable pipeline drugs in pharmaceutical mergers.  Historically, the FTC had accepted divestiture of pipeline…

Continue reading ›
DOJ Antitrust Division Improves the Enforceability of its Consent Decrees
Doyle, Barlow & Mazard PLLC

On January 26, 2018, the head of the Antitrust Division, Makan Delrahim delivered remarks to the NY State Bar where he discussed his views on behavioral remedies and consent decrees. He noted that the Division’s recent consent decrees reflect several provisions designed to ensure the Division can meaningfully enforce them.  Delrahim stated that the DOJ’s…

Continue reading ›
Business as Usual:  Trump Administration Targets Consummated Mergers
Doyle, Barlow & Mazard PLLC

Historically, the FTC and DOJ have sought to unwind consummated mergers that are deemed to be anticompetitive.  During Trump’s first year in office, the FTC and DOJ have demonstrated their willingness to unwind anticompetitive mergers that somehow sneaked by the regulators. FTC Seeks to Unwind Merger of Prosthetic Knee Manufacturers On December 20, 2017, the…

Continue reading ›
FTC Challenges Consummated Prosthetic Knee Manufacturer Merger
Doyle, Barlow & Mazard PLLC

On December 20, 2017, the FTC issued an administrative complaint seeking to unwind a merger between prosthetic knee manufacturers Otto Bock HealthCare North America, Inc. (“Otto Bock”) and FIH Group Holdings, LLC (“Freedom”). Background On September 22, 2017, Otto Bock and Freedom simultaneously executed a merger agreement and consummated their merger.  Within four days of…

Continue reading ›
Power Buyer Defense Not Enough: FTC Wins PI Hearing Against Sanford Health
Doyle, Barlow & Mazard PLLC

On December 15, 2017, a federal district court granted the Federal Trade Commission’s (“FTC”) and North Dakota Attorney General’s request for a preliminary injunction against Sanford Health’s proposed acquisition of Mid Dakota Clinic, a large multispecialty group, pending the FTC’s administrative trial on the merits scheduled for January of 2018.  FTC v. Sanford Health, et…

Continue reading ›
Senator Warren Criticizes Current State of Antitrust Enforcement
Doyle, Barlow & Mazard PLLC

On December 6, 2017, Senator Elizabeth Warren sharply criticized the state of antitrust enforcement in a speech at the Open Markets Institute. She said that antitrust enforcers adopted the Chicago School principles, which narrowed the scope of the antitrust laws and allowed mega-mergers to proceed resulting in many concentrated industries.  She believes that antitrust enforcers…

Continue reading ›
Trump’s FTC Challenges Tronox’s Acquisition of Cristal
Doyle, Barlow & Mazard PLLC

On December 5, 2017, the Federal Trade Commission (“FTC”) issued an administrative complaint challenging Tronox Limited’s proposed acquisition of Cristal, a merger of two of the top three suppliers of chloride process titanium dioxide (“TiO2”) in the North American market. Background On February 21, 2017, Tronox inked a deal to buy Cristal for $1.67 billion…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.